4th Circ. Sides With CMS' Definition Of 'Line-Extension Drug'

By Yeji Jesse Lee · April 10, 2024, 7:12 PM EDT

The Fourth Circuit on Wednesday affirmed a summary judgment ruling in favor of the Centers for Medicare & Medicaid Services in a rule challenge by Vanda Pharmaceuticals, which took issue with...

To view the full article, register now.